Cargando…
Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization
Giant prostatic hyperplasia (GPH) is a rare pathology traditionally treated with an open suprapubic prostatectomy. This procedure is risky, and fatal hemorrhagic complications can occur. Often, patients with GPH present with diminished renal function due to obstructive nephropathy, making them unfit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385503/ https://www.ncbi.nlm.nih.gov/pubmed/32742932 http://dx.doi.org/10.1016/j.ajur.2019.06.002 |
_version_ | 1783563799291232256 |
---|---|
author | Kably, Issam Bode, Alexander |
author_facet | Kably, Issam Bode, Alexander |
author_sort | Kably, Issam |
collection | PubMed |
description | Giant prostatic hyperplasia (GPH) is a rare pathology traditionally treated with an open suprapubic prostatectomy. This procedure is risky, and fatal hemorrhagic complications can occur. Often, patients with GPH present with diminished renal function due to obstructive nephropathy, making them unfit for less invasive endovascular therapies using traditional contrast agents. Here we present a case of a patient with intractable hematuria due to GPH, as well as diminished renal function, who was successfully treated using prostatic artery embolization with CO(2) digital subtraction arteriography as a contrast agent. |
format | Online Article Text |
id | pubmed-7385503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Second Military Medical University |
record_format | MEDLINE/PubMed |
spelling | pubmed-73855032020-07-30 Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization Kably, Issam Bode, Alexander Asian J Urol Case Report Giant prostatic hyperplasia (GPH) is a rare pathology traditionally treated with an open suprapubic prostatectomy. This procedure is risky, and fatal hemorrhagic complications can occur. Often, patients with GPH present with diminished renal function due to obstructive nephropathy, making them unfit for less invasive endovascular therapies using traditional contrast agents. Here we present a case of a patient with intractable hematuria due to GPH, as well as diminished renal function, who was successfully treated using prostatic artery embolization with CO(2) digital subtraction arteriography as a contrast agent. Second Military Medical University 2020-07 2019-06-22 /pmc/articles/PMC7385503/ /pubmed/32742932 http://dx.doi.org/10.1016/j.ajur.2019.06.002 Text en © 2020 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Kably, Issam Bode, Alexander Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization |
title | Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization |
title_full | Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization |
title_fullStr | Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization |
title_full_unstemmed | Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization |
title_short | Intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization |
title_sort | intractable hematuria due to giant prostatic hyperplasia effectively treated with prostatic artery embolization |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385503/ https://www.ncbi.nlm.nih.gov/pubmed/32742932 http://dx.doi.org/10.1016/j.ajur.2019.06.002 |
work_keys_str_mv | AT kablyissam intractablehematuriaduetogiantprostatichyperplasiaeffectivelytreatedwithprostaticarteryembolization AT bodealexander intractablehematuriaduetogiantprostatichyperplasiaeffectivelytreatedwithprostaticarteryembolization |